EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Incretins Predict Response to Enteral Nutrition Strategies in the EDEN Trial: A Secondary Analysis

Cole E Hansell iD, Hamam A Aneis, Zhiyi Yang, Georgios D Kitsios iD, Sachin P Yende iD, William G Bain iD, Yueting Wang, Seyed Mehdi Nouraie iD, Lokesh Sharma iD, Yanwu Zhao, Nancy Petro, Timothy D Girard iD und 8 weitere

American Journal of Respiratory and Critical Care Medicine · 13.07.2026

DOI: 10.1093/ajrccm/aamag366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Respiratory and Critical Care Medicine, online erschienen am 13.07.2026. Verfasst von Cole E Hansell und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, UPMC Presbyterian-Shadyside Hospitals, Pittsburgh, PA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

The Early versus Delayed Enteral Nutrition (EDEN) trial found no significant difference in mortality between trophic and full enteral nutrition strategies in acute respiratory distress syndrome (ARDS) patients. Heterogeneity of treatment effect (HTE) has been identified in prior ARDS trials. We previously identified intestine-derived incretin hormones (glucose-dependent insulinotropic peptide [GIP] and glucagon-like peptide [GLP]-1 as potential predictive biomarkers in the response to nutrition.

Objectives

To investigate incretins as biomarkers predictive of HTE in EDEN.

Methods

GIP, GLP-1, and host immune response biomarkers were measured from pre-intervention EDEN plasma samples. We investigated HTE with 60-day mortality as a primary outcome by testing interaction of treatment with circulating incretin levels in analyses adjusted for demographics, severity of illness, diabetes mellitus, and circulating interleukin-6, and assessed mortality by treatment arm across incretin tertiles. We additionally tested for HTE by de novo ARDS subphenotypes and by risk of mortality. Measurements & Main Results 889 participants were included (452 randomized to trophic and 437 to full enteral nutrition). GIP predicted HTE to enteral nutrition strategies (adjusted interaction p-value 0.01) with lower mortality from trophic feeds (14.1% vs 27.2% in full) in patients in the highest GIP tertile but similar mortality in other tertiles. GLP-1, ARDS subphenotypes, and baseline risk of mortality did not predict HTE.

Conclusions

GIP was unique among incretins in predicting HTE to enteral nutrition strategies in EDEN. Further studies are needed to validate our findings as GIP might serve as a biomarker to guide level of enteral nutrition for ARDS patients.

Schlagwörter

Stichwörter der Autor:innen

acute respiratory distress syndromeglucose-dependent insulinotropic peptideheterogeneity of treatment effectincretinsubphenotypes

Autor:innen und Institutionen

  • Department of Medicine, UPMC Presbyterian-Shadyside Hospitals, Pittsburgh, PA.
  • Department of Medicine, UPMC Mercy Hospital, Pittsburgh, PA.
  • Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
  • Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
  • Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA.
  • Acute Lung Injury and Infection Center of Excellence, University of Pittsburgh, Pittsburgh, PA.

ORCID-Profile: Cole E Hansell, Georgios D Kitsios, Sachin P Yende, William G Bain, Seyed Mehdi Nouraie, Lokesh Sharma, Timothy D Girard, David T Huang, Sadeesh Ramakrishnan, Jayshil Patel, Alison Morris, Bryan J McVerry, Yingze Zhang, Victor B Talisa, Faraaz A Shah

Förderung

  • NIGMS NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Hansell, C. E., Aneis, H. A., Yang, Z., Kitsios, G. D., Yende, S. P., Bain, W. G., Wang, Y., Nouraie, S. M., Sharma, L., Zhao, Y., Petro, N., Girard, T. D., Huang, D. T., Ramakrishnan, S., Patel, J., Morris, A., McVerry, B. J., Zhang, Y., Talisa, V. B., & Shah, F. A. (2026). Incretins Predict Response to Enteral Nutrition Strategies in the EDEN Trial: A Secondary Analysis. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1093/ajrccm/aamag366

Vancouver

Hansell CE, Aneis HA, Yang Z, Kitsios GD, Yende SP, Bain WG, et al. Incretins Predict Response to Enteral Nutrition Strategies in the EDEN Trial: A Secondary Analysis. American Journal of Respiratory and Critical Care Medicine. 2026. doi:10.1093/ajrccm/aamag366

BibTeX
@article{Hansell2026,
  author = {Hansell, Cole E and Aneis, Hamam A and Yang, Zhiyi and Kitsios, Georgios D and Yende, Sachin P and Bain, William G and Wang, Yueting and Nouraie, Seyed Mehdi and Sharma, Lokesh and Zhao, Yanwu and Petro, Nancy and Girard, Timothy D and Huang, David T and Ramakrishnan, Sadeesh and Patel, Jayshil and Morris, Alison and McVerry, Bryan J and Zhang, Yingze and Talisa, Victor B and Shah, Faraaz A},
  title = {Incretins Predict Response to Enteral Nutrition Strategies in the EDEN Trial: A Secondary Analysis},
  journal = {American Journal of Respiratory and Critical Care Medicine},
  year = {2026},
  doi = {10.1093/ajrccm/aamag366}
}
Kostenlos starten →